| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 133.254.449 $ | 98,66 | 2.104.034 | |||||||
| AbbVie Inc. | AbbVie Inc. COM | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 9.987.793 $ | 7,39 | 45.923 | |
| Amgen Inc. | Amgen Inc. COM | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 7.069.722 $ | 5,23 | 20.093 | |
| Gilead Sciences Inc. | Gilead Sciences Inc. COM | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 6.695.614 $ | 4,96 | 48.042 | |
| Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated COM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 5.411.618 $ | 4,01 | 12.119 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. COM | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 4.808.911 $ | 3,56 | 6.224 | |
| Alnylam Pharmaceuticals Inc. | Alnylam Pharmaceuticals Inc. COM | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 3.517.810 $ | 2,60 | 10.632 | |
| Insmed Inc | Insmed Inc COM PAR $.01 | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 3.315.695 $ | 2,45 | 20.277 | |
| BEONE MEDICINES LTD | BeOne Medicines Ltd. SPONSORED ADS | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 3.087.003 $ | 2,29 | 10.395 | |
| NATERA INC | Natera Inc. COM | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 2.828.859 $ | 2,09 | 14.145 | |
| United Therapeutics Corporation | United Therapeutics Corporation COM | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 2.793.529 $ | 2,07 | 4.711 | |
| Biogen Inc | Biogen Inc COM | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 2.713.834 $ | 2,01 | 14.803 | |
| Royalty Pharma PLC | Royalty Pharma PLC COM USD0.0001 CLASS A | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 2.673.800 $ | 1,98 | 55.739 | |
| Illumina Inc | Illumina Inc COM | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 2.348.473 $ | 1,74 | 19.053 | |
| Revolution Medicines Inc | Revolution Medicines Inc COM | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 2.282.944 $ | 1,69 | 23.475 | |
| Moderna Inc | Moderna Inc COM | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 2.225.954 $ | 1,65 | 43.818 | |
| AstraZeneca PLC | AstraZeneca PLC ORD USD0.25 | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 2.164.292 $ | 1,60 | 10.974 | |
| Argenx SE | Argenx SE SPONSORED ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 2.162.270 $ | 1,60 | 2.961 | |
| Incyte Corporation. | Incyte Corporation. COM | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 2.100.476 $ | 1,56 | 22.317 | |
| Viatris Inc | Viatris Inc COM | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 2.027.486 $ | 1,50 | 150.073 | |
| Bridgebio Pharma Inc | Bridgebio Pharma Inc COM | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 1.987.495 $ | 1,47 | 26.764 | |
| Alkermes PLC | Alkermes PLC COM USD0.01 | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 1.982.564 $ | 1,47 | 56.068 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC COM USD0.0001 | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 1.975.194 $ | 1,46 | 10.448 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc COM | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 1.913.787 $ | 1,42 | 14.527 | |
| Guardant Health Inc | Guardant Health Inc COM | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 1.903.376 $ | 1,41 | 20.606 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd SHS | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 1.893.904 $ | 1,40 | 68.372 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. COM | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 1.867.488 $ | 1,38 | 24.870 | |
| Exelixis, Inc. | Exelixis, Inc. COM | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 1.741.634 $ | 1,29 | 40.607 | |
| Medpace Holdings Inc. | Medpace Holdings Inc. COM | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 1.699.873 $ | 1,26 | 3.540 | |
| Biomarin Pharmaceutical Inc. | Biomarin Pharmaceutical Inc. COM | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 1.679.900 $ | 1,24 | 29.738 | |
| Apellis Pharmaceuticals Inc | Apellis Pharmaceuticals Inc COM | EC | 03753U106 | Long | Börsenkurs (Stufe 1) | 1.653.735 $ | 1,22 | 41.107 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc COM | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 1.653.399 $ | 1,22 | 26.370 | |
| Cytokinetics Inc | Cytokinetics Inc COM NEW | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 1.587.970 $ | 1,18 | 24.093 | |
| Vaxcyte Inc | Vaxcyte Inc COM | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 1.533.116 $ | 1,14 | 26.383 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG COM CHF0.03 | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 1.524.809 $ | 1,13 | 32.054 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics Inc COM | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 1.467.877 $ | 1,09 | 22.712 | |
| BioNTech SE | BioNTech SE SPONSORED ADS | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 1.436.212 $ | 1,06 | 16.159 | |
| Axsome Therapeutics Inc. | Axsome Therapeutics Inc. COM | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 1.381.062 $ | 1,02 | 8.171 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S SPONSORED ADR | EC | 04351P101 | Long | Börsenkurs (Stufe 1) | 1.366.433 $ | 1,01 | 5.974 | |
| COGENT BIOSCIENCES INC | Cogent Biosciences Inc. COM | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 1.337.604 $ | 0,99 | 34.752 | |
| Arcellx Inc | Arcellx Inc COMMON STOCK | EC | 03940C100 | Long | Börsenkurs (Stufe 1) | 1.337.079 $ | 0,99 | 11.645 | |
| TG Therapeutics Inc | TG Therapeutics Inc COM | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 1.303.055 $ | 0,96 | 39.225 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. COM | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 1.290.042 $ | 0,96 | 18.935 | |
| Scholar Rock Holding Corp. | Scholar Rock Holding Corp. COM | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 1.272.408 $ | 0,94 | 25.883 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc COM | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 1.219.162 $ | 0,90 | 2.329 | |
| Mirum Pharmaceuticals Inc. | Mirum Pharmaceuticals Inc. COM | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 1.208.330 $ | 0,89 | 13.080 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc COM | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 1.180.269 $ | 0,87 | 11.198 | |
| Amicus Therapeutics Inc. | Amicus Therapeutics Inc. COM | EC | 03152W109 | Long | Börsenkurs (Stufe 1) | 1.103.009 $ | 0,82 | 76.280 | |
| Rhythm Pharmaceuticals Inc | Rhythm Pharmaceuticals Inc COM | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 1.057.381 $ | 0,78 | 12.158 | |
| APOGEE THERAPEUTICS INC | Apogee Therapeutics Inc. COM | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 1.015.595 $ | 0,75 | 12.066 | |
| Kymera Therapeutics Inc | Kymera Therapeutics Inc COM | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 970.995 $ | 0,72 | 11.658 | |
| Twist Bioscience Corporation | Twist Bioscience Corporation COM | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 952.966 $ | 0,71 | 20.054 | |
| Viking Therapeutics Inc. | Viking Therapeutics Inc. COM | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 952.706 $ | 0,71 | 29.278 | |
| SUMMIT THERAPEUTICS INC | Summit Therapeutics Inc. COM | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 933.078 $ | 0,69 | 49.213 | |
| Nuvalent Inc | Nuvalent Inc COM | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 927.480 $ | 0,69 | 9.053 | |
| Acadia Pharmaceuticals Inc | Acadia Pharmaceuticals Inc COM | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 905.381 $ | 0,67 | 40.673 | |
| Travere Therapeutics Inc | Travere Therapeutics Inc COM | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 898.757 $ | 0,67 | 30.251 | |
| Sarepta Therapeutics Inc | Sarepta Therapeutics Inc COM | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 875.318 $ | 0,65 | 40.226 | |
| Celcuity Inc. | Celcuity Inc. COM | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 874.084 $ | 0,65 | 7.658 | |
| ARCUTIS BIOTHERAPEUTICS INC | Arcutis Biotherapeutics Inc. COM | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 869.906 $ | 0,64 | 36.923 | |
| Veracyte Inc | Veracyte Inc COM | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 859.524 $ | 0,64 | 26.685 | |
| LIQUIDIA CORP | Liquidia Corporation COM NEW | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 835.790 $ | 0,62 | 22.146 | |
| BEAM THERAPEUTICS INC | Beam Therapeutics Inc. COM | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 760.082 $ | 0,56 | 31.896 | |
| Ultragenyx Pharmaceuticals Inc | Ultragenyx Pharmaceuticals Inc COM | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 713.159 $ | 0,53 | 34.041 | |
| Praxis Precision Medicines Inc | Praxis Precision Medicines Inc COM NEW | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 674.021 $ | 0,50 | 2.092 | |
| GRAIL Inc | GRAIL Inc COM | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 663.054 $ | 0,49 | 12.830 | |
| Soleno Therapeutics Inc | Soleno Therapeutics Inc COM | EC | 834203309 | Long | Börsenkurs (Stufe 1) | 658.183 $ | 0,49 | 19.659 | |
| Recursion Pharmaceuticals Inc | Recursion Pharmaceuticals Inc CL A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 641.418 $ | 0,47 | 208.931 | |
| Krystal Biotech Inc | Krystal Biotech Inc COM | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 639.084 $ | 0,47 | 2.474 | |
| LEGEND BIOTECH CORP | Legend Biotech Corporation SPONSORED ADS | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 634.127 $ | 0,47 | 35.054 | |
| Intellia Therapeutics Inc | Intellia Therapeutics Inc COM | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 634.116 $ | 0,47 | 49.463 | |
| Adma Biologics Inc | Adma Biologics Inc COM | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 591.371 $ | 0,44 | 65.635 | |
| Akero Therapeutics Inc | Akero Therapeutics Inc | EC | 009CVR044 | Long | Schätzwert (Stufe 3) | 2 $ | 0,00 | 17.387 | |
| SANOFI SA - CVR | SANOFI SA - CVR | EC | Long | Schätzwert (Stufe 3) | 1 $ | 0,00 | 8.866 | ||
| 133.254.449 $ | 98,66 | 2.104.034 |